Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit

NCT07811180 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT07811180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07811180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
March 1, 2028
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, glucose, immune system and related disorders, intensive care unit (icu), isotope labeling, metabolism, sepsis